March 2022
1. TIERNEY BT, Tan Y, Yang Z, Shui B, et al
   Systematically assessing microbiome-disease associations identifies drivers of inconsistency in metagenomic research.
   PLoS Biol. 2022;20:e3001556.
   

   >> Share

   
   January 2022
2. CHEN ZY, Sun YT, Wang ZM, Hong J, et al
   Rab2A regulates the progression of nonalcoholic fatty liver disease downstream of AMPK-TBC1D1 axis by stabilizing PPARgamma.
   PLoS Biol. 2022;20:e3001522.
   

   >> Share

   
   December 2020
3. LU TW, Aoto PC, Weng JH, Nielsen C, et al
   Structural analyses of the PKA RIIbeta holoenzyme containing the oncogenic DnaJB1-PKAc fusion protein reveal protomer asymmetry and fusion-induced allosteric perturbations in fibrolamellar hepatocellular carcinoma.
   PLoS Biol. 2020;18:e3001018.
   

   >> Share

   
   
4. HE X, Li M, Yu H, Liu G, et al
   Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex.
   PLoS Biol. 2020;18:e3000803.
   

   >> Share

   
   March 2020
5. XIA B, Shi XC, Xie BC, Zhu MQ, et al
   Urolithin A exerts antiobesity effects through enhancing adipose tissue thermogenesis in mice.
   PLoS Biol. 2020;18:e3000688.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share